BAX and central nervous system cancer: Similarly, flow cytometry and fluorescence assays showed a higher percentage of apoptotic cells, i.e., around 39% increased expression of apoptotic protein Bax and Caspase-3, and greater Bax/Bcl-2 ratio in the PMMSN-PTX, confirming anti-glioma therapy.